Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
Mariangela.Biava@uniroma1.it
Mariangela Biava
Professore Ordinario
Struttura:
DIPARTIMENTO DI CHIMICA E TECNOLOGIE DEL FARMACO
E-mail:
Mariangela.Biava@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Nano-Based Drug Delivery Systems of Potent MmpL3 Inhibitors for Tuberculosis Treatment
PHARMACEUTICS
2022
Malaria transmission blocking compounds: a patent review
EXPERT OPINION ON THERAPEUTIC PATENTS
2022
Nano-Based Drug Delivery Systems of Potent MmpL3 Inhibitors for Tuberculosis Treatment
PHARMACEUTICS
2022
Therapeutic potential for coxibs-nitric oxide releasing hybrids in cystic fibrosis
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
2021
6-Fluorophenylbenzohydrazides inhibit Mycobacterium tuberculosis growth through alteration of tryptophan biosynthesis
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
2021
A novel class of dual-acting DCH-CORMs counteracts oxidative stress-induced inflammation in human primary tenocytes
ANTIOXIDANTS
2021
Metabolomic profiling of fresh goji (Lycium barbarum l.) berries from two cultivars grown in central italy: A multi-methodological approach
MOLECULES
2021
Dietary flavonoids: Nano delivery and nanoparticles for cancer therapy
SEMINARS IN CANCER BIOLOGY
2020
Sar analysis of small molecules interfering with energy-metabolism in mycobacterium tuberculosis
PHARMACEUTICALS
2020
Overcoming drug resistance in TB: An update
FUTURE MICROBIOLOGY
2020
Neutrophil-to-lymphocyte ratio, mediterranean diet, and bone health in coeliac disease patients: a pilot Study
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
2019
Mycobacterial tryptophan biosynthesis: a promising target for tuberculosis drug development?
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
2019
Novel pyrazole-containing compounds active against mycobacterium tuberculosis
ACS MEDICINAL CHEMISTRY LETTERS
2019
Chocolate consumers and lymphocyte-to-monocyte ratio: a working hypothesis from a preliminary report of a pilot study in celiac subjects
ANTIOXIDANTS
2019
Development of MmpL3 inhibitors for tuberculosis treatment
Medicinal Chemistry approaches to tuberculosis and trypanosomiasis
2019
In vivo potent BM635 analogue with improved drug-like properties
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
2018
Introduction to COX inhibitors
FUTURE MEDICINAL CHEMISTRY
2018
In vitro comprehensive analysis of VA692 a new chemical entity for the treatment of osteoarthritis
INTERNATIONAL IMMUNOPHARMACOLOGY
2018
1,5-Diarylpyrroles as potent antitubercular and anti-inflammatory agents
CHEMISTRY OF HETEROCYCLIC COMPOUNDS
2017
Pharmaceutical salt of BM635 with improved bioavailability
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
2017
1
2
seguente ›
ultima »
Progetti di Ricerca
Novel strategies to treat TB meningitis: from new active compounds to N2B delivery
Novel MmpL3 inhibitors-loaded niosomes to treat tuberculosis via lung delivery
Nuovi inibitori della via biosintetica del triptofano per la terapia della tubercolosi
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma